SR9011 10 mg | 99.60%
TargetMol
SR9011 is a REV-ERB agonist (IC50: 790 nM, REV-ERBα; IC50: 560 nM, REV-ERBβ).
More Information Supplier PageSR9011
Search Results
NOD-IN-1 5 mg | 99.43%
TargetMol
NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors.
More Information Supplier PageNOD-IN-1
NOD-IN-1 50 mg | 99.43%
TargetMol
NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors.
More Information Supplier PageNOD-IN-1
NOD-IN-1 1 mg | 99.43%
TargetMol
NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors.
More Information Supplier PageNOD-IN-1
NOD-IN-1 10 mg | 99.43%
TargetMol
NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors.
More Information Supplier PageNOD-IN-1
Macozinone 5 mg | 100.00%
TargetMol
Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
More Information Supplier PageMacozinone
Macozinone 50 mg | 100.00%
TargetMol
Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
More Information Supplier PageMacozinone
Macozinone 25 mg | 100.00%
TargetMol
Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
More Information Supplier PageMacozinone
NSC23005 Sodium 100 mg | Purity Not Available
TargetMol
NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.
More Information Supplier PageNSC23005 Sodium 10 mg | Purity Not Available
TargetMol
NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.
More Information Supplier PageNSC23005 Sodium
